[Case study] CFS/ME remission story severe patient [2008]
- Condition
- ME/CFS
- At worst
- Not stated
- Ill for
- Not stated
- Published
- Sep 2023
Summary
Treeman describes his daughter reaching roughly 85% function on weekly Cuvitru immunoglobulin, with IgG levels rising from 4.7 to 9.1 and persistent shingles/IBS improving by 3 months. He says gains faded after a subsequent infection, with recovery from that setback expected to take about another year, so this is a partial, interrupted improvement rather than a stable one.
Read it in their words
forums.phoenixrising.me — this page sells a treatment, program or service.
Similar stories
-
Camici et al: IVIG treatment for Long COVID, a case report
This previously healthy 39-year-old man received a course of IVIG (intravenous immunoglobulin) for Long COVID after other multidisciplinary interventions had failed to help, though the forum thread does not reproduce the specific dose, number of infusions,…
-
Dr Chia finds enterovirus ME/CFS patients given remdesivir remain in remission (Teodora)
A long COVID patient with associated enterovirus involvement. A Paxlovid course produced remarkable reductions in pain and improved energy, but stopping it triggered a horrendous symptomatic rebound. A later molnupiravir course gave only modest benefit by…
-
Radical Rest and Beyond
The author of Encephalogirl (who signs as Michelle) treats her ME/CFS-related dysautonomia and POTS with guanfacine and low-dose Abilify (titrated from 0.5mg down to 0.25mg after migraines, then back up to 0.5mg), an increased dose of low-dose naltrexone, a…
-
Treat ME Survey Results 2
Subcutaneous immunoglobulin (SCIG), given alongside a fecal microbiota transplant, for just over a year at time of report. Before treatment he was severely unwell, underweight at 118 pounds, and unable to attend school, with comorbid POTS and mast cell…